LogicBio Therapeutics (LOGC) Key Ratios

$12.85

up-down-arrow $6.17 (92.37%)

As on 03-Sep-2026 15:38EDT

Market cap

info icon

$587 Mln

Revenue (TTM)

info icon

$32 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

2

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- -24.88 -37.41 56.38
EBIT -- -- -- -- --
Net Profit -400.00 -650.00 61.33 24.39 14.42
EPS -- -- -- -- --
Book Value -- -- -- -- --
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsDec-25Dec-24Dec-23
EBIT-Margin info -149.00-96.33---183.72-114.29
Net Margin info ----------
Return on equity info -50.85-50.20-20.42-40.76-91.35
Return on Capital info -49.82-49.10-20.42-40.11-88.92
Return on Assets info -31.10-29.96-15.51-25.91-51.88
Debt to Equity (x) info --------0.03
ROCE

-20.42

--

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
-20.42
-40.11
-88.92
-58.01
-38.02
Peer Median
--
--
--
--
--
ROE

-20.42

--

Profit after tax / Average Net worth * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
-20.42
-40.76
-91.35
-59.31
-39.13
Peer Median
--
--
--
--
--
ROA

-15.51

--

Profit after tax / Average Total assets * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
-15.51
-25.91
-51.88
-36.89
-19.62
Peer Median
--
--
--
--
--
EBIT Margin

--

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
--
-183.72
-114.29
-69.70
-17.60
Peer Median
--
--
--
--
--
Net Margin

--

--

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
--
-174.42
-110.45
-67.25
-17.31
Peer Median
--
--
--
--
--
Revenue Growth

-1.00

--

Year on year growth in net sales

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
-1.00
-0.85
-0.50
-0.73
-0.18
Peer Median
--
--
--
--
--
EBIT Growth

--

--

Year on year growth in operating profit (EBIT)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
--
75.91
17.59
-8.45
41.84
Peer Median
--
--
--
--
--
Net Profit Growth

61.33

--

Year on year growth in profit after tax

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
61.33
76.34
17.45
-6.37
51.54
Peer Median
--
--
--
--
--
EPS Growth

--

--

Year on year growth in earnings per share

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
--
0.78
0.22
-0.49
0.64
Peer Median
--
--
--
--
--
Debt to Equity

--

--

Total debt / Net worth

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
--
--
0.03
0.03
0.02
Peer Median
--
--
--
--
--
Short term debt to equity ratio

--

--

(Short term borrowings / Net worth)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
--
--
0.70
0.49
0.01
Peer Median
--
--
--
--
--
Current Ratio

31.14

--

Current Assets / Current Liabilities and Provisions

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
31.14
31.20
2.09
2.51
2.73
Peer Median
--
--
--
--
--
Quick Ratio

--

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
--
--
--
--
2.73
Peer Median
--
--
--
--
--
Interest Coverage

--

--

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
--
--
--
-26.53
-22.96
Peer Median
--
--
--
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

--

--

Debtors outstanding / Net Sales * 100

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
--
--
2.44
2.45
0.82
Peer Median
--
--
--
--
--
Asset Turnover

--

--

Sales / Average Total Assets

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
--
0.15
0.47
0.55
1.13
Peer Median
--
--
--
--
--
Receivable days

--

--

Average Debtors / Sales * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
--
59.46
13.36
9.91
8.76
Peer Median
--
--
--
--
--
Inventory Days

--

--

Average Inventory / Sales * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
--
--
--
-1.94
-0.82
Peer Median
--
--
--
--
--
Payable days

--

--

Average Creditors / Cost of goods sold * 365

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
--
152.19
66.48
54.11
93.65
Peer Median
--
--
--
--
--
Cash Conversion Cycle

--

--

Receivable Days + Inventory Days - Payable Days

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
--
--
--
-46.14
-85.71
Peer Median
--
--
--
--
--
Price / Earnings

--

--

Current share price divided by earning per share in the last twelve months

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
--
-2.46
--
--
-0.21
Peer Median
--
--
--
--
--
Price / Book Value

--

--

Current share price divided by book value per share in the latest financial year

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
--
1.22
--
--
0.09
Peer Median
--
--
--
--
--
EV/EBITDA

--

--

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Dec-25
Dec-24
Dec-23
Dec-22
Dec-21
LogicBio Therapeutics (LOGC)
--
-0.46
--
--
2.99
Peer Median
--
--
--
--
--
loading...
loading...